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Abstract In order to assess the potentiality of Vibrio cholerae
ToxR protein and of bacteriophage V repressor as indicators of
the dimerization of periplasmic proteins in Escherichia coli, we
have constructed a series of plasmids encoding transmembrane
fusion proteins. The amino-terminal part, containing the DNA
binding domain of either ToxR or V repressor, is located in the
cytoplasm and acts as reporter for dimerization. As models of
periplasmic proteins we have used alkaline phosphatase (a dimer)
and L-lactamase (a monomer). Both the expression level and the
distance between the transmembrane segment and the periplas-
mic protein substantially affect the activity of the reporter
domains.
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1. Introduction
ToxR is the central regulator that co-ordinates the expres-
sion of several virulence factors in Vibrio cholerae. The pro-
tein acts at the transcriptional level, activating the cholera
toxin genes located on the ctx operon (for a review, see [1]).
ToxR is a single-spanning membrane protein containing a
cytoplasmic amino-terminal domain which binds the ctx pro-
moter (amino acids [aa] 1^182), a transmembrane segment (aa
183^198) and a periplasmic carboxy-terminal domain (aa 199^
294) [2]. If ToxR is expressed in Escherichia coli from a strong
promoter, such as that of the tet gene of the plasmid pBR322,
activation by ToxR is 15^30-fold and does not depend on the
ToxS protein [2,3]. However, if ToxR is expressed under the
control of toxR promoter, it activates transcription 3^5 times
and its activity depends upon ToxS, which interacts with
ToxR at the periplasmic level [3,4].
When ToxR is fused to the enzyme alkaline phosphatase
(PhoA) it can also activate the ctx promoter. The fusion
ToxR210-PhoA, incorporating 12 ToxR aa residues past the
transmembrane domain, when expressed from a strong pro-
moter (i.e. the tet promoter of pBR322) and in absence of
ToxS, highly activates ctx transcription [2]. However, if
ToxR-PhoA fusions are expressed at a lower level, a short
fusion behaves di¡erently from a long fusion. Thus, under
the control of toxR promoter, a fusion in which ToxR is
truncated only ¢ve residues downstream of the transmem-
brane segment (ToxR203-PhoA), activates transcription at
least as well as ToxR and independently of ToxS. In contrast,
the activity of the hybrid ToxR286-PhoA, where the fusion
joint is 88 aa residues from ToxR transmembrane domain
(eight residues from ToxR C-terminus), requires ToxS for
transcriptional activation [4]. It has been shown that ToxS
protects ToxR286-PhoA from periplasmic proteolysis, which
explains why in this circumstance the alkaline phosphatase
dimer is unable to activate ToxR [4]. However, it is not
known to what extent the distance between ToxR transmem-
brane segment and the PhoA domain is a critical factor for
the activity of ToxR in absence of ToxS.
Because PhoA is enzymatically active as a periplasmic
dimer, it has been suggested that ToxR active conformation
might be dimeric [2]. Further support for this model derives
from the fact that ToxR is able to dimerize the amino-termi-
nal domain of V phage repressor [5]. In agreement with the
dimerization model are also the results obtained with other
ToxR fusion proteins in which two domains with di¡erent
tendencies to dimerize, PhoA, GCN4 leucine zipper domain
and monomeric maltose binding protein have been fused to
ToxR at the periplasmic level [6]. As a further development of
this system, the ToxR activator has been used as an indicator
for the association [7] and the folding stability [8] of dimers of
immunoglobulin VL domains and for the analysis of residues
critical for the dimerization of the transmembrane segment of
glycophorin A [9]. In contrast, another study has shown that
hybrid proteins in which ToxR periplasmic domain was re-
placed with either PhoA, GCN4 leucine zipper domain or L-
lactamase (Bla), all activate transcription from the ctx pro-
moter at high level. Since Bla is a monomeric protein, the
authors suggested that dimerization is not a requirement for
ToxR activity in E. coli [10].
The bacteriophage V repressor provides a sensitive in vivo
assay for protein dimerization. It consists of an amino-termi-
nal domain (1^92) which binds DNA, and a carboxy-terminal
domain (93^236) which mediates dimerization. The repressor
binds to DNA as a dimer, but the DNA binding domain
alone dimerizes ine⁄ciently and requires the carboxy-terminal
domain to be functional (for a review, see [11]). The system
using the repressor amino-terminal domain as a reporter for
dimerization was ¢rst introduced to analyze the sequence re-
quirements of GCN4 leucine zipper [12]. Since then it has
been shown that the carboxy-terminal domain of the repressor
can be functionally substituted by other cytoplasmic domains
which also dimerize. Activity of the repressor can be easily
tested by assaying sensitivity to V phage infection of bacteria
expressing the fusion protein.
The present work was originally undertaken with a view to
using ToxR and V repressor amino-terminal domains as ge-
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netic probes to detect the dimerization of periplasmic proteins.
These turned out not to be as robust as expected. Here we
show that: (i) a small variation in the length of the sequence
between the periplasmic domain and ToxR transmembrane
domain drastically a¡ects the activity of the two reporter do-
mains; (ii) the V repressor activity correlates with the dimeri-
zation ability of the domain present in the periplasm, but only
up to a certain level of concentration.
2. Materials and methods
Strains were propagated in LB medium. Antibiotics concentrations:
chloramphenicol (Cm) 25^50 Wg/ml; kanamycin (Km) 50 Wg/ml; am-
picillin (Ap) 200 Wg/ml, unless di¡erently indicated.
PhoA activity was inferred from the color of colonies after over-
night growth at 37‡C on LB plates containing 5-bromo-4-chloro-3-
indolyl phosphate (BCIP) 30 Wg/ml and 24 h incubation at 4‡C.
In order to test ToxR transcriptional activity the plasmids were
transformed in E. coli strain Q442V2418. This strain was obtained
by lysogenization of Q442 (F3 i3 lac amU281 argEam rif nal) with
V2418 containing the hybrid pctx: :lacZ. L-Galactosidase (Bgal) activ-
ity was assayed according to the method of Miller [13].
Lambda repressor activity was assayed after transforming each ex-
pression vector in E. coli strains XL1-blue [14] or Q537 (F3 mcrA
mcrB rK3 mK i lac amU281 argEam gal3 rif nal sup‡). 24 h old
transformant colonies were inoculated in LB supplemented with 1%
maltose and 10 mM MgSO4 Cm (50 Wg/ml) or Km (50 Wg/ml). Over-
night cultures were tested by cross-streak test performed with a stock
of V2001, which carries the deletion KH54 in the cI gene that e¡ec-
tively prevents lysogenization. The protocol used to quantitate re-
pressor activity is explained in the legend of Fig. 2.
Bla activity was scored determining the minimum inhibiting con-
centration of Ap for individual cells. 24 h old transformant colonies
were inoculated in LB containing Cm (50 Wg/ml). 25 Wl of a 1036
dilution of overnight cultures (about 50 cfu) was plated on LB agar
containing serial concentrations of Ap and, as a control, on a Cm (50
Wg/ml) plate. Plates were inspected for colony growth after 18 h in-
cubation at 37‡C.
Recombinant DNA procedures were performed according to stand-
ard methods [14,15].
Except for pAC103 and pAC105, which confer Km resistance, all
the expression vectors used in this work confer Cm resistance. The
toxR gene segments were PCR ampli¢ed from the plasmid pVM7 [16].
pAC1 and pAC2 (C.G. Koh, M.K. Trower and S. Brenner, unpub-
lished), pMTC3, pMTC8 and pMTC9 [17] are derivatives of pA-
CYC184 [18] and were constructed previously. pAC3 and pAC4 de-
rive from pAC1 and pAC2 respectively, replacing the PstI-KpnI
fragment with the toxR fragment ampli¢ed with oligonucleotides R1
and R2 and restricted with PstI and KpnI. pAC5 derives from pAC4
replacing the BstEII-SalI fragment with the BstEII-SalI fragment of
pVM7. pAC6 and pAC7 derive from pAC1 and pAC2 respectively,
replacing the PstI-KpnI fragment with the toxR fragment ampli¢ed
with oligonucleotides R1 and R3 and restricted with PstI and KpnI.
pAC11 originates from a derivative of pACYC184 [18], which con-
tains the promoter of the kan gene of Tn5 (Y. Mikawa and S. Bren-
ner, unpublished), replacing the PstI-SalI fragment with the PstI-SalI
fragment of pAC7. pAC15 and pAC16 derive from the same vector
replacing the PstI-SalI fragment with the PstI-SalI fragment of pAC3
and pAC4 respectively. pAC13 derives from pAC11 replacing the
KpnI-SalI fragment with the KpnI-SalI fragment of pAC1. pAC8 de-
rives from pMTC8 replacing the KpnI-SalI fragment with the KpnI-
SalI fragment of pAC2. pAC51 derives from pAC9 eliminating the
XhoI-XhoI fragment. pAC117 derives from pAC116 eliminating the
XhoI-XhoI fragment. pAC116 is a plasmid that, similar to pAC55,
encodes the aa 1^101 of the repressor. pAC9 was obtained in a
three-molecular ligation reaction and derives from pMTC8 replacing
the SacI-SalI fragment with the following fragments: (i) the toxR
fragment ampli¢ed by oligonucleotides R3 and R4 and restricted
with SacI and KpnI; (ii) the KpnI-SalI fragment of pAC2. pAC19
derives from pAC9 replacing the BspHI-SalI fragment with the
BspHI-SalI fragment of pAC4. pAC55 derives from pAC9 replacing
the NsiI-SalI fragment with the NsiI-SalI fragment of pAC53, which
was obtained replacing the PstI-SacI fragment with the cI fragment
ampli¢ed with oligonucleotides R35 and R36 and restricted with PstI
and SacI. pAC104 derives from pAC19 replacing the KpnI-SalI frag-
ment with KpnI-SalI fragment of pAC1. pAC122 and pAC123 derive
from pAC55 replacing the SacI-XhoI fragment with the SacI-XhoI
fragment of pAC19 and pAC104 respectively. pAC125 derives from
pAC122 replacing the SacI-KpnI fragment with the toxR fragment
ampli¢ed with oligonucleotides R4-R90 and restricted with SacI-
KpnI. pAC127 derives from pAC122 replacing the SacI-KpnI frag-
ment with the toxR fragment ampli¢ed with oligonucleotides R4-
R96 and restricted with SacI-KpnI. pAC124, pAC126 and pAC128
derive from pAC55, pAC125 and pAC127 respectively replacing the
KpnI-XhoI fragment with the KpnI-XhoI fragment of pAC1. To ob-
tain pAC103 and pAC105, ¢rst the PstI-SalI fragment of pAC19 was
subcloned into pAC66, a Bluescript (Stratagene) derivative, to gener-
ate pAC102, which confers resistance to Ap. pAC103 derives from
pAC76, a Bluescript derivative which confers resistance to Kan, but
not to Ap, replacing the ApaLI-XbaI fragment with the ApaLI-XbaI
fragment of pAC102. pAC105 derives from pAC103 replacing the
KpnI-SalI fragment with the fragment KpnI-SalI of pAC1. Oligonu-
cleotide sequences: R1 (5P-CACCTGCAGGGAGATACTGGGA-
CATT-3P) ; R2 (5P-AGTGGTACCGCTGCCACTAGTTAGGGGTT-
TAAAGCTGGA-3P) ; R3 (5P-AGTGGTACCTGGGTTAGTGAG-
CAGTAATA-3P) ; R4 (5P-ATAGAGCTCGAAGAAGAGATGGC-
TCGCGA-3P) ; R35 (5P-GATCCTGCAGATCTAGGAGT-3P) ; R36
(5P-CACGAGCTCATACTCACTTCTAAGTG-3P) ; R90 (5P-TATG-
GTACCGCTGGATTGGCTTGGGTTAG-3P) ; R96 (5P-CACGGTA-
CCTAGGGGTTTAAAGCTGGATT-3P).
3. Results
PhoA and Bla are normally located in the periplasmic space
and are not functional in the cytoplasm. Since the activity of
these enzymes is easy to test, they have been fused to carboxy-
terminally truncated versions of membrane proteins to assess
their topology [19,20]. As one is a dimer and the other a
monomer, we chose them since a di¡erence between a PhoA
chimera and a Bla chimera would validate the hypothesis that
the activity of the ToxR and V repressor moieties depends on
periplasmic dimerization.
The structure and activity of ToxR fusion proteins are sum-
marized in Fig. 1. All use ToxR as cytoplasmic reporter. In
the upper part of the ¢gure, expression is from a pACYC184
plasmid derivative which contains a tightly repressed copy of
the 434 phage pL promoter ensuring a constant low level of
transcription [21]. The hybrid ToxR210-Bla, encoded by plas-
mid pAC3, conferred resistance to Ap, indicating that Bla is
translocated into the periplasmic space. In the fusion
ToxR210-PhoA, encoded by pAC4, PhoA replaces Bla. As
inferred by the blue color of the colonies on an indicator plate
containing BCIP, this fusion is able to translocate PhoA into
the periplasm. In addition a vector producing the whole ToxR
protein was constructed (pAC5, not shown). In order to test
ToxR transcriptional activity these constructs were trans-
formed in E. coli strain Q442V2418 which contains the hybrid
gene pctx: :lacZ as a reporter. None of these three constructs
activated transcription over the background value. However,
a shorter fusion ToxR201-PhoA (pAC7) did, as shown by a
two-fold increase in L-galactosidase activity (Fig. 1). These
data indicate that the ability of a ToxR-PhoA fusion to acti-
vate transcription is susceptible to relatively small variations
in the length of the periplasmic linker connecting the ToxR
transmembrane segment to PhoA. They also con¢rm previous
¢ndings that in the absence of ToxS and at low levels of
expression, a short ToxR-PhoA fusion has higher capacity
in activating transcription than wild-type ToxR [4]. To deter-
mine if, in such conditions of expression, ToxR activity is
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in£uenced by the dimerization capability of the domain
present in the periplasm, we also generated the short fusion
ToxR201-Bla (pAC6). However this construct did not confer
proper resistance to Ap (i.e. it did not allow growth of iso-
lated colonies), indicating that in this case the Bla moiety, if
translocated, is not functional or unstable.
In order to express these gene fusions at a higher expression
level, the same constructs have been subcloned into an other
derivative of the plasmid pACYC184 [18] which contains the
strong constitutive promoter of km gene (Y. Mikawa and S.
Brenner, unpublished). These are summarized in the lower
part of Fig. 1. As with pAC6, plasmid pAC13 encoding
ToxR201-Bla displayed no resistance to ampicillin. Plasmid
pAC11, directing the synthesis of ToxR201-PhoA, activated
transcriptional activity at a very high level, similar to that
elicited by the plasmid pVM7 [2] which encodes the wild-
type ToxR protein and was used as a positive control (not
shown). In addition this activation was substantially higher in
comparison to the similar vector expressing the long construct
ToxR210-PhoA (pAC16). These results con¢rm the in£uence
of the periplasmic linker on ToxR activity. The long ToxR-
Bla fusion (pAC15) activated transcription at a level very
similar to the long ToxR-PhoA fusion (pAC16) which is an
indication that, in a condition of elevated expression, ToxR
activity is not dependent upon the dimerization capability of
the domain attached on the periplasmic side of the membrane.
In the next experiment we estimated the di¡erence between
the concentration of fusion protein expressed at high level and
those expressed at low level. Because the vectors pAC3 and
pAC15 direct the synthesis of identical products, the Bla ac-
tivity is proportional to the amount of enzyme present in the
periplasmic space. XL1-blue cells transformed with pAC3 and
pAC15 were plated on agar containing concentrations of Ap
50, 100, 150 etc. (Wg/ml). While pAC3 grew only at Ap con-
centration of 50 Wg/ml, bacteria harboring pAC15 were able
to grow with a concentration as high as 100 Wg/ml. This in-
dicates that in the two conditions of expression, the number of
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Fig. 2. Vectors encoding V-ToxR fusion proteins. NA: not applica-
ble. Linker length: see legend of Fig. 1. Except pAC103 and
pAC105, all vectors are derivatives of plasmid pACYC184. Repres-
sor activity was quantitated as follows: 5 Wl of 10-fold serial dilu-
tions of a 1010 pfu/ml phage stock containing 5^5U107 pfu/ml were
spotted on bacterial lawns poured on V plates containing Cm (50
Wg/ml) or Km (50 Wg/ml). Highest lysing phage dilution (HLPD) is
the highest phage dilution that produces visible bacterial lysis. The
level of V resistance conferred by each recombinant protein is ex-
pressed as the ratio of HLPD that causes lysis in the strain produc-
ing that protein, and HLPD that causes bacterial lysis in the un-
transformed strain.
Fig. 1. Vectors encoding ToxR fusion proteins. The dashed line sep-
arates the constructs expressed at low level from those expressed at
high level. Linker length: number of aa residues intervening between
the end of ToxR transmembrane segment (L198) and either Bla or
PhoA. For the vectors expressing the fusions at low level the Bgal
activity values are the means for three independent experiments.
pAC3 and pAC15 encode ToxR aa residues 1^210 followed by the
sequence SGSG, fused to Thr4 of the mature form of Bla. pAC4
and pAC16 are identical to pAC3 and pAC15 respectively, except
that the mature sequence of PhoA, starting from Thr2, replaces Bla.
pAC6 and pAC13 encode ToxR aa residues 1^201 followed by a
single Gly, fused to Bla. pAC7 and pAC11 are identical to pAC6
and pAC13 except that PhoA replaces Bla.
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hybrid proteins present in the cell di¡ers by a factor which is
smaller than 3.
In the second part of this work we replaced the DNA bind-
ing domain of ToxR with the amino-terminal domain of V
repressor. The structure and activity of the fusion proteins
are outlined in Fig. 2. As in the previous case, protein fusions
were ¢rst produced at low level. Plasmids pMTC3 and
pMTC8 [17] served as positive controls (Fig. 2A). E. coli
strain XL1-blue synthesizing intracellularly the wild-type re-
pressor molecule (pMTC3) and a variant with a 9 aa poly-
linker sequence between position 155 and position 158
(pMTC8, not shown), displayed very high level of phage re-
sistance. In contrast, bacteria producing two truncated ver-
sions of the repressor, aa 1^101 in pAC117 (Fig. 2A) and
aa 1^155 in pAC51 (not shown) were as sensitive as the parent
XL1-blue strain. Plasmids directing either the intracellular
synthesis of V155-Bla (pMTC9) [17] or V155-PhoA (pAC8)
(Fig. 2A), or the periplasmic secretion of wild-type Bla or
PhoA (not shown), displayed also high sensitivity to phage
lysis.
In the fusions ToxR201-PhoA the ¢rst 126 aa residues have
been replaced by aa residues 1^101 of V repressor (pAC55).
This construct translocated the PhoA moiety into the periplas-
mic space and conferred a level of resistance to V phage as
high as the complete repressor molecule (Fig. 2B). Since the
repressor molecule acts as a dimer and because the protein
produced by pAC55 appeared to be a fully functional trans-
membrane form of repressor, we decided to verify the pheno-
type contributed by a similar Bla fusion (pAC124) (Fig. 2B).
However such a chimera as well as the short ToxR201-Bla
fusion constructed before, did not confer ampicillin resistance
to single bacterial cells and cannot be compared to the PhoA
fusion. We therefore constructed the PhoA fusion pAC125
and the Bla fusion pAC126 which add four ToxR aa residues
at the linker level. The new Bla fusion conferred resistance to
Ap and indicated a high level of phage sensitivity. In addition,
the new PhoA fusion still displayed a very high level of re-
pressor activity which suggests that, at the level of expression
used, repressor activity is de¢nitely dependent upon the
dimerization capability of the domain attached to the mem-
brane (Fig. 2B).
In order to evaluate the e¡ect of the length of the periplas-
mic linker on repressor activity, we have constructed two lon-
ger V-ToxR-PhoA fusions. The longest fusion pAC122, incor-
porating a 16 aa linker conferred a level of phage resistance
105 lower than the 8 aa linker fusion pAC125. pAC127 encod-
ing a 12 aa linker gave a level of resistance intermediate be-
tween pAC122 and pAC125. Two similar V-ToxR-Bla fusions,
encoded by the vectors pAC128 and pAC123 displayed sensi-
tivity to V phage (Fig. 2B). As with ToxR-PhoA fusions, these
data indicate that the activity of the repressor is sensitive to
small variations in the length of the periplasmic linker. We
also determined the e¡ect of shortening the ToxR sequence on
the cytoplasmic side. However, in the context of the long
periplasmic linker fusion, a 50 aa residue deletion of the
ToxR cytoplasmic spacer separating the repressor DNA bind-
ing domain from the transmembrane domain did not increase
the phage resistance (not shown).
Next we analyzed the response of V-ToxR fusions in a
condition of more elevated expression. As a starting point
we may consider the vectors pAC19 and pAC104 (Fig. 2C).
pAC19 expresses at low level a V-ToxR-PhoA construct which
is identical to pAC122 except that it encompasses the ¢rst 155
aa residues of the repressor (vs. aa 1^101 of pAC122). This
region extends well beyond the DNA binding domain (1^92).
This was originally done to include in the fusions the sequence
required for RecA mediated cleavage of the repressor. In the
same way, pAC104 encodes a V-ToxR-Bla fusion similar to
pAC123. Both pAC19 and pAC104 supported growth of sin-
gle plaques of V at the lowest phage dilution indicating a high
level of phage sensitivity. To explore the e¡ect of a higher
expression level these constructs have been subcloned in var-
ious expression vectors. We found that as a consequence of
the synthesis from a high copy number vector and under
constitutive expression of lac promoter, not only the PhoA
fusion (pAC103), but also the Bla fusion (pAC105) conferred
a very high level of resistance to phage lysis (Fig. 2C). Bac-
teria expressing the truncated version of the repressor in sim-
ilar conditions, were still as sensitive as the parent strain (not
shown). Next, the two vectors expressing the Bla fusion at
lower level (pAC104) and at higher level (pAC105) were trans-
formed in Q537 and plated on LB-agar containing various
concentrations of Ap. It was determined that transformants
containing pAC104 could grow at a concentration of Ap of
175 Wg/ml but not at one of 200 Wg/ml. In contrast bacteria
harboring pAC105 were able to grow with at a concentration
of 500 Wg/ml but not at one of 600 Wg/ml. These data indicate
that pAC105 directed the synthesis of a fusion protein whose
amount is between 2.5 and 3.4 times that produced by
pAC104.
4. Discussion
The DNA binding domains of ToxR and V repressors have
been applied as genetic indicators of the dimerization of both
periplasmic and membrane proteins [5^9]. It is important to
validate the applicability of these reporter systems to di¡erent
experimental conditions. We have found that the length of the
periplasmic linker between the transmembrane segment of
ToxR and PhoA, introduced as a model of dimeric protein,
is critical ; incremental changes of as few as 4 aa residues
substantially a¡ect V sensitivity. One possibility is that the
proximity of PhoA to the membrane enhances its capacity
to dimerize the DNA binding domain. Alternatively a shorter
linker might a¡ect the level of full length fusion protein
present in the membrane in view of a lower sensitivity to
periplasmic proteases [4]. It should be noted that in some of
the ToxR-PhoA hybrid proteins formerly constructed [2,4] a
17 aa residue linker, generated by the insertion of TnPhoA
[19], was interposed between the last ToxR aa residue and
PhoA amino-terminus, Pro6 of the mature protein. In con-
trast, in the hybrid protein constructed by Kolmar et al. [6]
ToxR is fused directly to Pro6. It follows that the fusion
ToxR210-PhoA [6] is in fact 10 aa residues shorter than
ToxR203-PhoA [4]. This observation may account for the
higher transcriptional activation displayed by the ¢rst fusion
in comparison to the latter, but this conclusion is limited by
the fact that the expression conditions of these two fusions
were not identical.
Two previous studies based on ToxR fusion proteins [6,10]
have reached opposite conclusions about periplasmic dimeri-
zation as a requirement for ToxR activation (see Section 1). A
possible explanation for this divergence is the fact that
although in both studies the constructs were expressed from
FEBS 19892 25-2-98
R. Jappelli, S. Brenner /FEBS Letters 423 (1998) 371^375374
medium copy number plasmids, the ToxR fusion proteins
were expressed at quite di¡erent levels due to the presence
of di¡erent promoters, toxR in one instance [6], tet in the
other case [10]. Although in case of the fusions incorporating
the ToxR DNA binding domain our experiments at a lower
expression level were not conclusive (although pAC7 dis-
played ToxR transcriptional activity, the vector pAC6 encod-
ing the similar Bla fusion did not conferred Ap resistance), at
a higher level of expression the dimerization of the periplas-
mic domain is not required for the activation of ToxR. In case
of the fusions incorporating V repressor, we have found that
at a low expression level a PhoA fusion, but not a Bla fusion,
displays repressor activity. However following an increase in
the expression level, both fusions confers a high grade of
protection to phage lysis. Dimerization appears to be critical
only within a narrow concentration range, because bacteria
harboring the plasmid pAC105 have a level of V-ToxR-Bla
fusion protein that is only about three times higher than those
containing plasmid pAC104. We have provided evidence that
repressor activity does depend on the dimerization ability of
the domain present in the periplasm, but only within certain
levels of concentration. Our result is consistent with the data
from a recent study [22] that has shown that when ToxR is
overexpressed in V. cholerae, the amount of protein increases
2.7 times above the normal level. A biochemical cross-linking
analysis indicated that when ToxR is overexpressed, it forms
both ToxR homodimers and ToxR-ToxS heterodimers; how-
ever, at normal expression levels only ToxR-ToxS hetero-
dimers are found [22].
Acknowledgements: We are grateful to J.J. Mekalanos for providing
the plasmid pVM7 and to M.T. Cairns, C.G. Koh, Y. Mikawa and
M.K. Trower (our laboratory) for plasmids.
References
[1] Di Rita, V.J. (1992) Mol. Microbiol. 6, 451^458.
[2] Miller, V.L., Taylor, R.K. and Mekalanos, J.J. (1987) Cell 48,
271^279.
[3] Miller, V.L., Di Rita, V.J. and Mekalanos, J.J. (1989) J. Bacter-
iol. 171, 1288^1293.
[4] Di Rita, V.J. and Mekalanos, J.J. (1991) Cell 64, 29^37.
[5] Dziejman, M. and Mekalanos, J.J. (1994) Mol. Microbiol. 13,
485^494.
[6] Kolmar, H., Hennecke, F., Gotze, K., Janzer, B., Vogt, B.,
Mayer, F. and Fritz, H.-J. (1995) EMBO J. 14, 3895^3904.
[7] Kolmar, H., Frisch, C., Kleemann, G., Gotze, K., Stevens, F.J.
and Fritz, H.-J. (1994) Biol. Chem. Hoppe-Seyler 375, 61^70.
[8] Kolmar, H., Frisch, C., Gotze, K. and Fritz, H.-J. (1995) J. Mol.
Biol. 251, 471^476.
[9] Langosch, D., Brosig, B., Kolmar, H. and Fritz, H.-J. (1996)
J. Mol. Biol. 263, 525^530.
[10] Ottemann, K.M. and Mekalanos, J.J. (1995) Mol. Microbiol. 15,
719^731.
[11] Sauer, R.T., Jordan, S.R. and Pabo, C.O. (1990) Adv. Protein
Chem. 40, 1^61.
[12] Hu, J.C., O’Shea, E.K., Kim, P.S. and Sauer, R.T. (1990) Science
250, 1400^1403.
[13] Miller, J.H. (1992) in: A Short Course in Bacterial Genetics,
pp. 72^74, Cold Spring Harbor Laboratory Press, Cold Spring
Harbor NY.
[14] Ausubel, F.M., Brent R., Kingston R.E., Moore D.D., Seidman
J.G., Smith J.A. and Struhl, K. (1994) Current Protocols in Mo-
lecular Biology, Wiley, New York.
[15] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular
Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY.
[16] Miller, V.L. and Mekalanos, J.J. (1984) Proc. Natl. Acad. Sci.
USA 81, 3471^3475.
[17] Cairns, M.T., Green, A.J., White, P.M., Johnston, P.G. and
Brenner, S. (1997) Gene 185, 5^9.
[18] Chang, A.C.Y. and Cohen, S.N. (1978) J. Bacteriol. 134, 1141^
1156.
[19] Manoil, C. and Beckwith, J. (1985) Proc. Nat. Acad. Sci. USA
82, 8129^8133.
[20] Broome-Smith, J.K. and Spratt, B.G. (1986) Gene 49, 341^349.
[21] Koh, C.G. (1992) New Approaches for Mapping Bacterial Ge-
nomes, Ph.D. Thesis, University of Cambridge.
[22] Ottemann, K.M. and Mekalanos, J.J. (1996) J. Bacteriol. 178,
156^162.
FEBS 19892 25-2-98
R. Jappelli, S. Brenner /FEBS Letters 423 (1998) 371^375 375
